Archive for the 'Psychology news' Category

Consumers Blame Organizations For Crises More When The Injured Party Is A Consumer, Rather Than A Member Of The Organization (source: Medical News Today)

Posted on April 19 2010 by NewsBot

When crises such as the recent Toyota recalls occur, public relations practitioners develop strategies to minimize damage to company images. University of Missouri researchers have found that consumers blame an organization for crises more when customers a… (source: Medical News Today) – Share on TwitterShare on FacebookRSS news feeds and Widgets on Feedzilla.com

Men Run Marathons To Compete, Women To Feel Good (source: Medical News Today)

Posted on April 19 2010 by NewsBot

Men are more likely to run a marathon for personal goal achievement and competition reasons than women. These are the findings of a study into people’s motivations to run a marathon presented on the 16th April 2010 at the British Psychological Society’s An… (source: Medical News Today) – Share on TwitterShare on FacebookNews widgets and RSS feeds on Feedzilla.com

Uncovering Early Stages Of Alzheimer’s Disease

Posted on April 19 2010 by NewsBot

A major Australian study has provided new insights into the loss of structure in regions of the brain and its potential association with Alzheimer’s Disease. The findings recently reported in Neurology suggest a build-up of deposits of the protein amyloid-beta in a region of the brain known as the temporal inferior cortex. The region is connected to the hippocampus, which is involved in memory…

Uncovering Early Stages Of Alzheimer’s Disease

Posted on April 19 2010 by NewsBot

A major Australian study has provided new insights into the loss of structure in regions of the brain and its potential association with Alzheimer’s Disease. The findings recently reported in Neurology suggest a build-up of deposits of the protein amyloid-beta in a region of the brain known as the temporal inferior cortex. The region is connected to the hippocampus, which is involved in memory…

Why the same campaigns to keep children out of gangs work in one city but not another

Posted on April 19 2010 by NewsBot

In each of two cities, a team of local agencies launches a campaign to keep children from joining gangs. The two use similar tactics, combining counseling, tutoring and recreation. One initiative shows great results; the other makes barely a dent. Why the difference? New research suggests that one program may have failed because the right people weren’t talking.

Obesity gene, carried by more than a third of the US population, leads to brain tissue loss

Posted on April 19 2010 by NewsBot

Researchers have found that an obesity-related gene carried by nearly half of all Central and Western Europeans may also be associated with brain degeneration.

Gene variant may protect memory and thinking skills in older people

Posted on April 19 2010 by NewsBot

New research shows a gene variant may help protect the memory and thinking skills of older people.

Key brain regions, basal ganglia and cerebellum, talk directly with each other

Posted on April 19 2010 by NewsBot

Researchers have found new evidence that the basal ganglia and the cerebellum, two important areas in the central nervous system, are linked together to form an integrated functional network.

Implications of ‘intelligent design’ for human behavior

Posted on April 19 2010 by NewsBot

Although evolutionists and creationists strongly disagree about the role that intelligent design plays in the origins of bodies and brains, they curiously agree about the role that intelligent design plays in the origins of human inventiveness. However, both camps would do well to focus less on perceived foresight and purpose and more on the actual origins of behavior, according to one expert.

Impax Pharmaceuticals Completes Enrollment In APEX-PD Phase III Trial Of IPX066 In Parkinson’s Disease

Posted on April 18 2010 by NewsBot

Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that it has completed enrollment of its APEX-PD trial. APEX-PD is a multinational Phase III trial of its late-stage drug candidate IPX066 in subjects with early Parkinson’s disease (PD)…